Long-term follow up of patients affected by pulmonary carcinoid at the Istituto Nazionale Tumori of Milan: a retrospective analysis

由 Pusceddu, S, Catena, L, Valente, M, Buzzoni, R, Formisano, B, Del Vecchio, M, Ducceschi, M, Tavecchio, L, Fabbri, A, Bajetta, E
出版 2010

Endocrinological and clinical evaluation of two doses of formestane in advanced breast cancer.

由 Bajetta, E., Zilembo, N., Buzzoni, R., Noberasco, C., Di Leo, A., Bartoli, C., Merson, M., Sacchini, V., Moglia, D., Celio, L.
出版 1994

Endocrinological and clinical evaluation of exemestane, a new steroidal aromatase inhibitor.

由 Zilembo, N., Noberasco, C., Bajetta, E., Martinetti, A., Mariani, L., Orefice, S., Buzzoni, R., Di Bartolomeo, M., Di Leo, A., Laffranchi, A.
出版 1995

Combination goserelin and tamoxifen therapy in premenopausal advanced breast cancer: a multicentre study by the ITMO group. Italian Trials in Medical Oncology.

由 Buzzoni, R., Biganzoli, L., Bajetta, E., Celio, L., Fornasiero, A., Mariani, L., Zilembo, N., Di Bartolomeo, M., Di Leo, A., Arcangeli, G.
出版 1995

FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.

由 Bajetta, E., Di Bartolomeo, M., Carnaghi, C., Buzzoni, R., Mariani, L., Gebbia, V., Comella, G., Pinotti, G., Ianniello, G., Schieppati, G., Bochicchio, A. M., Maiorino, L.
出版 1998

Uracil/ftorafur/leucovorin combined with irinotecan (TEGAFIRI) or oxaliplatin (TEGAFOX) as first-line treatment for metastatic colorectal cancer patients: results of randomised pha...

由 Bajetta, E, Di Bartolomeo, M, Buzzoni, R, Mariani, L, Zilembo, N, Ferrario, E, Lo Vullo, S, Aitini, E, Isa, L, Barone, C, Jacobelli, S, Recaldin, E, Pinotti, G, Iop, A
出版 2007